Federation Des Caisses Desjardins Du Quebec Essa Pharma Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Essa Pharma Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 2,050 shares of EPIX stock, worth $410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,050
Previous 4,050
49.38%
Holding current value
$410
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EPIX
# of Institutions
39Shares Held
20.9MCall Options Held
428KPut Options Held
182K-
Bvf Inc San Francisco, CA11.7MShares$2.33 Million0.12% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.36MShares$872,4050.05% of portfolio
-
Morgan Stanley New York, NY1.9MShares$380,8120.0% of portfolio
-
Bank Of America Corp Charlotte, NC592KShares$118,3660.0% of portfolio
-
Lmr Partners LLP London, X0541KShares$108,1960.0% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $8.81M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...